Fondazione Policlinico Universitario A Gemelli-Rome

Rome 00168

2 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumors, CCNE1 Amplification, Carcinosarcoma, Endometrial Cancer, Esophageal Adenocarcinoma, Gastric Cancer, HER2-negative Breast Cancer, HR+ Breast Cancer, KRAS G12C-mutated Solid Tumors, Lung Cancer, KRAS, NRAS, HRAS-mutated NSCLC, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer, Myotonic Dystrophy Type 1 (DM1)

Studies at this site

• Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC — Recruiting now
• Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 — Recruiting now
• (VELA) Study of BLU-222 in Advanced Solid Tumors — Stopped early